文献速递急性肾损伤血液净化与透析

危重症患者间歇性血液透析的管理

Management of Intermittent Hemodialysis in the Critically Ill Patient.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-01-26

间歇性血液透析仍是ICU中体外肾脏替代治疗(KRT)的基石,可作为急性肾损伤(AKI)的一线治疗或从连续/延长间歇治疗转换后的二线治疗。通常每周提供3次,因为未证明更频繁透析有临床获益。与其他KRT模式相比,间歇性血液透析的主要挑战是血流动力学不稳定,缓解措施中降温透析液和升高透析液钠浓度的证据最强,但证据质量弱。

要点

  • 间歇性血液透析在ICU通常每周3次,未证明更频繁透析有临床获益。
  • 主要挑战是血流动力学不稳定,与超滤和/或渗透性转移导致血管内容量减少超过代偿性血浆再充盈有关。
  • 降温透析液和升高透析液钠浓度缓解血流动力学不稳定的证据最强,但证据质量弱、样本量有限。

核心结论

  • 间歇性血液透析将继续是危重症AKI患者重要且常用的KRT模式,尤其在资源有限地区。
  • 亟需在临床试验中统一KRT相关血流动力学不稳定的定义,并稳健测试应对策略。

研究设计与样本

  • 本文为综述,检索范围未在摘要中报告。

主要发现

  • 间歇性血液透析通常每周3次,因为未证明更频繁透析有临床获益。
  • 与其他KRT模式相比,间歇性血液透析的主要挑战是血流动力学不稳定。
  • 血流动力学不稳定发生于超滤和/或渗透性转移导致血管内容量减少超过代偿性血浆再充盈时。
  • 间歇性血液透析触发的心肌顿抑独立于超滤,也可能参与其中。
  • 危重症患者因多器官功能障碍无法产生足够代偿性生理反应,间歇性血液透析的血流动力学效应可能被放大。

关键数值与推荐

  • 缓解KRT相关血流动力学不稳定的干预措施中,降温透析液和升高透析液钠浓度的证据最强。
  • 支持常规使用这些及其他干预措施的证据弱,因研究质量差和样本量有限。

临床怎么用

  • 应根据细胞外容量和其他参数的动态变化,持续评估和调整血液透析处方(包括需要额外治疗),并确保给予足够剂量的血液透析。
  • 原文未据此给出其他推荐。

局限性

  • 支持常规使用降温透析液、升高透析液钠浓度及其他干预措施的证据弱,因研究质量差和样本量有限。
  • 亟需在临床试验中统一KRT相关血流动力学不稳定的定义,并稳健测试应对策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intermittent hemodialysis remains a cornerstone of extracorporeal KRT in the intensive care unit, either as a first-line therapy for AKI or a second-line therapy when patients transition from a continuous or prolonged intermittent therapy. Intermittent hemodialysis is usually provided 3 days per week in this setting on the basis that no clinical benefits have been demonstrated with more frequent hemodialysis. This should not detract from the importance of continually assessing and refining the hemodialysis prescription (including the need for extra treatments) according to dynamic changes in extracellular volume and other parameters, and ensuring that an adequate dose of hemodialysis is being delivered to the patient. Compared with other KRT modalities, the cardinal challenge encountered during intermittent hemodialysis is hemodynamic instability. This phenomenon occurs when reductions in intravascular volume, as a consequence of ultrafiltration and/or osmotic shifts, outpace compensatory plasma refilling from the extravascular space. Myocardial stunning, triggered by intermittent hemodialysis, and independent of ultrafiltration, may also contribute. The hemodynamic effect of intermittent hemodialysis is likely magnified in patients who are critically ill due to an inability to mount sufficient compensatory physiologic responses in the context of multiorgan dysfunction. Of the many interventions that have undergone testing to mitigate hemodynamic instability related to KRT, the best evidence exists for cooling the dialysate and raising the dialysate sodium concentration. Unfortunately, the evidence supporting routine use of these and other interventions is weak owing to poor study quality and limited sample sizes. Intermittent hemodialysis will continue to be an important and commonly used KRT modality for AKI in patients with critical illness, especially in jurisdictions where resources are limited. There is an urgent need to harmonize the definition of hemodynamic instability related to KRT in clinical trials and robustly test strategies to combat it in this vulnerable patient population.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Chan RJ, Helmeczi W, Canney M, et al. Management of Intermittent Hemodialysis in the Critically Ill Patient. Clin J Am Soc Nephrol. 2023. PMID: 35840348. doi:10.2215/CJN.04000422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。